Meet the Anthrobots: Like nothing you’ve ever seen before. These awe-inspiring genetic marvels, created by a team of researchers led by Gizem Gumuskaya at Tufts University, are a groundbreaking leap in biobotics. The Anthrobots, formed from human tracheal cells, are tiny but mighty, with the amazing ability to navigate across surfaces, while also encouraging neuron growth.
This extraordinary discovery builds upon previous research from the laboratories of Michael Levin and Josh Bongard. The team’s earlier work produced the Xenobots, which were created from frog embryo cells and showcased remarkable abilities. However, the Anthrobots have surpassed expectations by demonstrating unique capabilities in promoting neuron growth without any genetic modifications.
In a move that surprises the scientific community, it has been discovered that unmodified Anthrobots can trigger substantial regrowth, creating a bridge of neurons as thick as healthy tissue. This breakthrough raises fascinating questions about the potential of these constructs, with wide-ranging implications for the field of biobotics and therapeutic application.
Furthermore, the Anthrobots, made from patient-derived tracheal cells, offer a tantalizing glimpse into the future of healing and therapy. With the ability to self-assemble, move around, encourage neuron growth, and eventually biodegrade, these multifunctional bots offer endless possibilities for regeneration and the treatment of disease.
So what sets Anthrobots apart from other biobots? Unlike Xenobots, they can be created from adult cells, allowing the seamless integration of a patient’s cells for therapeutic work. This means there’s no need to fret about immune responses, genetic modifications, or any risk of unintended spread outside the lab. The team’s original vision of using biobots as new therapeutic tools has now taken a giant leap forward, with these remarkable Anthrobots leading the way.
